Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Clinical trial NCT07400588 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07400588
- Sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-09-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.